CAPTRUST Financial Advisors’s Opus Genetics IRD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$146K	Hold	32,000	–	–	﹤0.01%	2747
2025 Q4	$64.3K	Hold	32,000	–	–	﹤0.01%	2659
2025 Q3	$52.8K	Hold	32,000	–	–	﹤0.01%	2558
2025 Q2	$30.1K	Buy	32,000 +4,000	+14%	+$3.71K	﹤0.01%	2461
2025 Q1	$27.5K	Hold	28,000	–	–	﹤0.01%	2308
2024 Q4	$33.3K	Buy	28,000 +10,000	+56%	+$11.5K	﹤0.01%	2259
2024 Q3	$23.6K	Hold	18,000	–	–	﹤0.01%	2258
2024 Q2	$27.5K	Hold	18,000	–	–	﹤0.01%	2171
2024 Q1	$36.2K	Hold	18,000	–	–	﹤0.01%	2096
2023 Q4	$54.2K	Hold	18,000	–	–	﹤0.01%	2581
2023 Q3	$60.3K	Sell	18,000 -1	-0%	-$4	﹤0.01%	2469
2023 Q2	$78.1K	Sell	18,001 -1,500	-8%	-$7.12K	﹤0.01%	2406
2023 Q1	$73.1K	Buy	+19,501	New	+$70K	﹤0.01%	2191
2022 Q4	–	Sell	-19,501	Closed	-$39K	–	2204
2022 Q3	$39K	Buy	19,501 +18,001	+1,200%	+$38.8K	﹤0.01%	2000
2022 Q2	$3K	Hold	1,500	–	–	﹤0.01%	4359
2022 Q1	$5K	Buy	+1,500	New	+$5.13K	﹤0.01%	4185

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAPTRUST Financial Advisors's IRD Position: Q1 2026 in Review

CAPTRUST Financial Advisors held its Opus Genetics (IRD) position steady in Q1 2026 at 32,000 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #2747.

CAPTRUST Financial Advisors first reported a position in IRD in Q1 2022 and has held it in 16 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

CAPTRUST Financial Advisors held 32,000 shares of Opus Genetics worth $146K as of Q1 2026.
CAPTRUST Financial Advisors left its Opus Genetics share count unchanged in Q1 2026.
Opus Genetics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2747 holding.
CAPTRUST Financial Advisors first reported a position in Opus Genetics in Q1 2022 and has held it in 16 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.